Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients
Recruiting now · Phase 2/Phase 3
Conditions studied: Acute Kidney Injury
In brief
The investigators propose a single-center, randomized, controlled trial to determine whether early initiation of proton pump inhibitor (PPI), pantoprazole, will decrease acute kidney injury (AKI) for trauma patients presenting with hemorrhagic shock compared to routine timing of initiation of PPI. Kidney injury will be assessed by the urinary kidney injury biomarkers, and the incidence, severity and AKI-free days within first week and major adverse kidney events (MAKE) at day 30. The specific aims of the study will be achieved by a cohort of 100 patients to receive either early(study) or routine (control) administration of pantoprazole for 2 days after the initial injury insult.
Key facts
- Study ID
- NCT06531642
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 100
- Starts
- 2024-09-07
- Expected to finish
- 2026-09-01
- Last updated by the study team
- 2026-02-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adult patient (≥18 years of age)
- Patient meets hemorrhagic shock criteria:
- Hypovolemic shock from traumatic acute bleeding
- Systolic blood pressure ≤ 90 mmHg AND tachycardia (HR ≥ 108) at presentation to the ED; OR
- Systolic blood pressure ≤ 70 mmHg at presentation to the ED.
You may not qualify if…
- Patients <18 years of age
- Patients known to be actively on renal replacement therapy
- Cardiac arrest prior to ED arrival or who are deemed to have expected survival of less than 24 hours
- History of PPI sensitivity or allergy
- Patient who are already enrolled in other trials prior to ED arrival and these trials do not allow co-enrollment
- Patient who presents with ongoing GI bleeding that will require higher dose of GI prophylaxis
- Vulnerable populations such as pregnant women and prisoners
Where it is running
- Memorial Hermann Texas Medical Center — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.